Association of<i>Fusobacterium</i>species in pancreatic cancer tissues with molecular features and prognosis

Kei Mitsuhashi, Katsuhiko Nosho, Yasutaka Sukawa, +20

Oncotarget

Association of<i>Fusobacterium nucleatum</i>with clinical and molecular features in colorectal serrated pathway

Miki Ito, Shinichi Kanno, Katsuhiko Nosho, +17

International Journal of Cancer

DysbiosisBacteriologyGastroenterologyPathologyHuman Gut Microbiota +16

Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway

Katsuhiko Nosho, Hisayoshi Igarashi, Masanori Nojima, +21

Carcinogenesis

PathologyColorectal Cancer SurvivalMirna ArrayCancer BiologyTumor Biology +16

Horizontal transfer of nonconjugative plasmids in a colony biofilm of<i>Escherichia coli</i>

Sumio Maeda, Miki Ito, Tsuyako Ando, +6

FEMS Microbiology Letters

BiofilmsColony BiofilmGram-negative BacteriologyTransformed CellsMedicine +8

Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer

Hisayoshi Igarashi, Hiroyoshi Kurihara, Kei Mitsuhashi, +19

Annals of Surgical Oncology

OncologyMedicinePathologyColorectal CancerMetastatic Colorectal Cancer +5

Periventricular and deep white matter leukoaraiosis have a closer association with cerebral microbleeds than age

Shigeki Yamada, Munehiro Saiki, Takeshi Satow, +4

European Journal of Neurology

MicroRNA‐31 expression in relation to <i>BRAF</i> mutation, CpG island methylation and colorectal continuum in serrated lesions

Miki Ito, Kei Mitsuhashi, Hisayoshi Igarashi, +18

International Journal of Cancer

Cimp StatusGeneticsPathologyEpigeneticsTumor Biology +18

Cell-to-Cell Transformation in Escherichia coli: A Novel Type of Natural Transformation Involving Cell-Derived DNA and a Putative Promoting Pheromone

Rika Etchuuya, Miki Ito, Seiko Kitano, +3

PLoS ONE

Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy

Kei Mitsuhashi, Itaru Yamamoto, Hiroyoshi Kurihara, +14

Oncotarget

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)

Yuji Miura, Yasutaka Sukawa, Shuichi Hironaka, +26

Gastric Cancer

Cisplatin TherapyGastrointestinal OncologyMedicineTrastuzumab TherapyPathology +5